Provision of cellular blood components to CMV ‐seronegative patients undergoing allogeneic stem cell transplantation in the UK: survey of UK transplant centres
ConclusionsThe survey demonstrated a surprisingly high rate (22.7%) of centres continuing to provide blood components from CMV‐seronegative donors despite SaBTO guidance.
Source: Transfusion Medicine - Category: Hematology Authors: S. Morton, A. Peniket, R. Malladi, M. F. Murphy Tags: ORIGINAL ARTICLE Source Type: research
More News: Blood Transusion | Cytomegalovirus | Hematology | Pediatrics | Stem Cell Therapy | Stem Cells | Transplants